Search Videos and More
Molecular Profiling Named Top Advance of 2021 by ASCO
An American Society of Clinical Oncology (ASCO) collaborative report named the use of molecular profiling the top advance of 2021, but also identified priority areas for future research.Retroperitoneoscopic Robot-Assisted Partial Nephrectomy on Morbidly Obese Patient with Tumor in the Upper Pole
Benjamin T. Ristau, MD, MHA, Randall A. Lee, MD, and Alexander Kutikov, MD, FACS, present a retroperitoneoscopic robot-assisted partial nephrectomy on a morbidly obese patient.